Last updated: 11 September 2020 at 6:23pm EST

Christopher Schreiber Net Worth




The estimated Net Worth of Christopher C Schreiber is at least $62.6 mil dollars as of 1 January 2020. Mr. Schreiber owns over 5,201 units of Akers Biosciences Inc stock worth over $12,638 and over the last 6 years he sold AKER stock worth over $0. In addition, he makes $50,000 as President y Chief Executive Officer. Principal Executive Officer at Akers Biosciences Inc.

Mr. Schreiber AKER stock SEC Form 4 insiders trading

Christopher has made over 1 trades of the Akers Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 5,201 units of AKER stock worth $12,638 on 1 January 2020.

The largest trade he's ever made was exercising 5,201 units of Akers Biosciences Inc stock on 1 January 2020 worth over $12,638. On average, Christopher trades about 1,734 units every 0 days since 2019. As of 1 January 2020 he still owns at least 5,201 units of Akers Biosciences Inc stock.

You can see the complete history of Mr. Schreiber stock trades at the bottom of the page.





Christopher Schreiber biography

Christopher C. Schreiber serves as President, Chief Executive Officer. Principal Executive Officer of the Company. Principal executive officer of the Company. Principal executive officer of the Company. Principal executive officer of the Company. He has been our director since August 8, 2017 and currently serves as our Executive Chairman. Mr. Schreiber has been our President since July 21, 2020. Mr. Schreiber combines over 30 years of experience in the securities industry. As the managing director of capital markets at Taglich Brothers, Inc., Mr. Schreiber builds upon his extensive background in capital markets, deal structures, and syndications. Prior to his time at Taglich Brothers, Inc., he was a member of the board of directors of Paulson Investment Company, a 40-year-old full service investment banking firm. In addition, Mr. Schreiber serves as a director and partner of Long Island Express North, an elite lacrosse training organization for teams and individuals. He also volunteers on the board of directors for Fox Lane Youth Lacrosse, a community youth program. Mr. Schreiber is a graduate of Johns Hopkins University, where he received a Bachelor’s Degree in Political Science.

What is the salary of Christopher Schreiber?

As the President y Chief Executive Officer. Principal Executive Officer of Akers Biosciences Inc, the total compensation of Christopher Schreiber at Akers Biosciences Inc is $50,000. There are no executives at Akers Biosciences Inc getting paid more.



How old is Christopher Schreiber?

Christopher Schreiber is 54, he's been the President y Chief Executive Officer. Principal Executive Officer of Akers Biosciences Inc since 2020. There are 2 older and 2 younger executives at Akers Biosciences Inc. The oldest executive at Akers Biosciences Inc is Stuart Benson, 59, who is the Chief Financial Officer.

What's Christopher Schreiber's mailing address?

Christopher's mailing address filed with the SEC is C/O TAGLICH BROTHERS INC, 709 NEW YORK AVENUE, SUITE 209, HUNTINGTON, NY, 11743.

Insiders trading at Akers Biosciences Inc

Over the last 10 years, insiders at Akers Biosciences Inc have traded over $81,316 worth of Akers Biosciences Inc stock and bought 194,718 units worth $575,645 . The most active insiders traders include Bay Capital Management Lp G..., Billy Joe White y Joshua Silverman. On average, Akers Biosciences Inc executives and independent directors trade stock every 183 days with the average trade being worth of $52,855. The most recent stock trade was executed by Bay Capital Management Lp G... on 28 February 2020, trading 638 units of AKER stock currently worth $1,793.



What does Akers Biosciences Inc do?



Complete history of Mr. Schreiber stock trades at Akers Biosciences Inc

Persona
Trans.
Transacción
Precio total
Christopher C Schreiber
Exec. Chairman y Presidente
Uso de opción $16,643
1 Jan 2020


Akers Biosciences Inc executives and stock owners

Akers Biosciences Inc executives and other stock owners filed with the SEC include: